LON:OVB Ovoca Bio (OVB) Share Price, News & Analysis → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free OVB Stock Alerts GBX 0.82 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range 0.72▼ 0.9050-Day Range 0.55▼ 0.9952-Week Range 0.45▼ 14.80Volume288,739 shsAverage Volume227,748 shsMarket Capitalization£672,870.00P/E RatioN/ADividend Yield0.83%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsStock AnalysisChartCompetitors Get Ovoca Bio alerts: Email Address Ad Stansberry ResearchMysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.Find out what it is and see how you can get in with just a few dollars. About Ovoca BioOvoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for women health. It is developing BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.Read More OVB Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OVB Stock News HeadlinesAugust 2, 2022 | finance.yahoo.comOvoca Bio plc (OVB.L)February 25, 2022 | reuters.comOVB.I - Ovoca Bio PLC Profile | ReutersSee More Headlines Receive OVB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ovoca Bio and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:OVB CUSIPN/A CIKN/A Webwww.ovocabio.com Phone353 1 661 9819FaxN/AEmployees5Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-2,330,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-33.98% Return on Assets-4.89% Debt Debt-to-Equity Ratio4.80 Current Ratio3.70 Quick Ratio1.77 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowGBX 0.83 per share Price / Cash Flow1.00 Book ValueGBX 6 per share Price / Book0.14Miscellaneous Outstanding Shares81,560,000Free FloatN/AMarket Cap£672,870.00 OptionableNot Optionable Beta0.68 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Kirill Andreyevich Golovanov (Age 46)Interim Chairman of the Board & CEO Comp: $125.07kMr. Dmitriy NikitashenkoVice President of FinanceReneta NikolovaCorporate SecretaryKey CompetitorsPort Erin Biopharma InvestmentsLON:PEBISalvaRx GroupLON:SALVNuformixLON:NFXReNeuron GroupLON:RENEPhysiomicsLON:PYCView All Competitors OVB Stock Analysis - Frequently Asked Questions How have OVB shares performed in 2024? Ovoca Bio's stock was trading at GBX 0.90 at the beginning of 2024. Since then, OVB stock has decreased by 8.3% and is now trading at GBX 0.83. View the best growth stocks for 2024 here. What other stocks do shareholders of Ovoca Bio own? Based on aggregate information from My MarketBeat watchlists, some companies that other Ovoca Bio investors own include CarMax (KMX), Beazer Homes USA (BZH), Chesapeake Lodging Trust (CHSP), Mitie Group (MTO), New World Development (NDVLY), Parsley Energy (PE), Bilibili (BILI), Bango (BGO), Belmont Resources (BEA) and BioDelivery Sciences International (BDSI). How do I buy shares of Ovoca Bio? Shares of OVB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:OVB) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ovoca Bio plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.